The present review describes the work carried out during the last 20 years in the field of the radioprotective activity and toxicity of several classes of organosilicon and organogermanium compounds (i.e. metallathiazolidines, metalladithioacetals, metallatranes and germathianes).
Introduction
During the 20-year period between 1978 and 1998 the Dlgation Gnrale pour I'Armement and Dpartement de Chimie Pharmacologie, France, sponsored a coordinated antiradiation drug development program. The objective of this program was to develop a drug or combination of drugs with organometallated compounds which could be taken by military personnel or other populations to protect them from the effects of ionizing radiations in a nuclear weapons attack, medical treatments or, in general, all radiation exposition.
During the research program approximately 562 compounds were chemically synthesized and tested in mice for their radioprotective properties.
The vast majority of these compounds were metallathiazolidines, metalladithioacetals of Nsubstituted cysteamine, methylcysteamine, N-(2-thioethyl)-l,3-diaminopropane, N-substituted cysteamine or methylcysteamine by naphthylmethylimidazoline and N-substituted naphthylmethylimidazoline.
120 compounds of these derivatives are characterized by a dose reduction factor (DRF) 
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Sila-and germathiazolidines of N-substituted cysteamine, methylcysteamine, N-(2-thioethyl)-1,3-diaminopropane and N-substituted cysteamine or methylcysteamine by naphthylmethylimidazoline were prepared according to two methods of heterocyclisation already described in the literature [1] [2] [3] .
Compounds
Method A The action of diorganosilicon and-germanium dichloride [3] (in stoichiometric amounts) on Nsubstituted cysteamine, methylcysteamine, N-(2-thioethyl)-l,3-diaminopropane and N-substituted cysteamine or methylcysteamine by naphthylmethylimidazoline in refluxing anhydrous tetrahydrofuran in the presence of freshly distilled triethylamine gave by a cyclisation reaction, with elimination of hydrochloric acid from M-CI and SH and NH [4] A radioprotective study of metallathiazolidines shows that the silylated and germylated derivatives have a greater biological activity and a lower toxicity than that of the corresponding organic compounds [1] (Table I). 3. Sila-and germadithioacetals
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Sila-and germadithioacetals of N-substituted cysteamine, methylcysteamine, N-(2-thioethyl)-1,3-diaminopropane, N-substituted cysteamine and methylcysteamine by naphthylmethylimidazoline and N-substituted naphthylmethylimidazoline were also obtained by two methods C and D [10] .
Method C The action of diorganosilicon and-germanium dichloride [3] on two equivalents of Nsubstituted cysteamine, methylcysteamine, N-(2-thioethyl)-l, 3- [1] 12 [1] 13 [1] 14 [1] 15 [1] 16 [1] 17 [1] 18 [1] 19 [8] 20 [8] 21 [9] R2 CH3 C6H5 CH3 C6H5 
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Silatranes and germatranes have been synthesized according to two methods already known in the literature [13] [14] [15] [16] [17] [18] .
Method E This method is the simplest and most general. The reaction of trimethoxymetallanes, R-M(OMe)3 (M Si, Ge), obtained by the action of tetramethoxymetallanes [10] with cysteamine, methylcysteamine and N-(2-thioethyl)-l,3-diaminopropane in the presence of triethanolamine leads to corresponding metallatranes (Scheme 5). Male CD1 mice (Charles River, France), 25 g body weight, were used. The compounds were injected intraperitoneally 15, 90, 120 or 180 rain before irradiation. The irradiation dose was LD100/30 days for untreated mice (7.5, 7.75, 8, 8.25 or 8.3 Gy, according to the irradiation date) or a 2 Gy greater dose. When necessary, other irradiation doses (between 8.5-13.5 Gy were tested in order to evaluate the irradiation LD50/30 days of protected mice. The injected dose of the compound was equal to one-half or one-eighth of the LD50 value which had been determined previously. The radioprotective effect was evaluated by the Dose Reduction Factor (DRF), which is the ratio between the LD50/30 days of treated mice and that of control mice (between 6.5 and 6.75 Gy, according to the date). The objective of this work was to incorporate potentially radioprotective organic groups in organometallic structures such as metallathiazolidines, metalladithioacetals, metallatranes and germathianes so as to decrease their toxicity and increase their radioprotective activity.
Tables through Vl summarize the radiation protection obtained in mice after intraperitoneal administration in miglyol solution of the organosilylated and organogermylated derivatives described. Generally, these organometallic compounds have a lower toxicity and a radioprotective activity equal to or greater than that of the starting organic derivatives (namely cysteamine [19] , methylcysteamine [10] and N-substituted cysteamine or methylcysteamine [6, 9] and N-substituted naphthylmethylimidazoline [7, 12] ). We have to underline that in some cases this great radioprotective activity was obtained with organosilylated or organogermylated derivatives injected in lower doses, expressed in mmol fraction, than those used for starting organic compounds.
The analysis of the toxicity and powerful radioprotective effect of all compounds presented in Table shows that the metallathiazolidines have generally a good radioprotective activity and lower toxicity compared with starting organic derivatives.
Several compounds in this series (1, 2, 6, 9 and 10) exhibit a dose reduction factor (DRF) of 1.5-1.75.
The LD50 dose of each compound indicated that they were weakly toxic (500-1500 mg.kg-1).
-Derivative 1 (DRF 1.6; LD5o 800 mg.kg-1) at one-half of LD5o (the maximum tolerated dose, MTD) this product protects 93 % and 90 % of mice at 10 Gy 15 or 120 minutes after injection and 70 % survival at 12 Gy 15 minutes before irradiation. At one-eighth of the LD5o, there was a 16 % survival at a dose of 10 Gy.
-Derivative 2 (DRF 1.5; LD50 750 mg.kg-1) at one-half of LD5o 95 % and 89 % protection were obtained at doses of 10 and 12 Gy. At one-eighth of the LD5o, there was still 75 % survival at a dose of 10 Gy.
-Derivative 6 (DRF 1.6; LD50 600 mg.kg-1) at one-half of LDs0 100 % and 90 % survival were obtained at doses of 7.5 and 9.5 Gy and 50 % survival was observed at a dose of 7.5 Gy. At one-eighth of the LD5o, there was a 30 % survival at a dose of 7.5 Gy.
-Derivative 9 (DRF 1.6; LD50 600 mg.kg) at one-half of LD5o 100 %, 70 % and 40 % survival were obtained at doses of 9.5, 11.5 and 13.5 Gy. At one-eighth of the LD5o, there was a 50 % survival at a dose of 9.5 Gy.
-Derivative 10 (DRF 1.75; LD50 500 mg.kg-1) at one-half of LD5o 80 %, 70 % and 70 % survival were obtained at doses of 9.5, 11.5 and 13. 5 Gy.
The analysis of the results reported in Table II shows that the siladithioacetals and  germadithioacetals 31, 36, 38, 39, 42, 4, 5 and 47 have an important radioprotective activity (DRF between 1.5-1.7).
-Derivative 31 (DRF 1.5; LD5o 100 mg.kg-1) at one-half of LD5o 100 % protection was observed at a dose of 7.75 Gy. At one-eighth of the LD5o, there was still 50 % survival at a dose of 7.75 Gy.
-Derivative 36 (DRF>1.6; LD5o 600 mg.kg-) at one-half of LD5o 100 % and 95 % survival were obtained at doses of 10 and 12 Gy.
-Derivative 38 (DRF>1.5; LD5o 600 mg.kg-1) at one-half of LD5o 90 % survival was observed at doses of 9.5 or 11.5 Gy. At one-eighth of the LD5o, there was 45 % survival at a dose of 9.5 Gy.
-Derivative 39 (DRF 1.5; LD5o 800 mg.kg"1) at one-half of LD5o 85 %, 70 % and 60 % survival were obtained at doses of 9.5 and 11.5 Gy. At one-eighth of the LD5o, there was 33 % survival at a dose of 9.5 Gy.
-Derivative 42 (DRF 1.5; LD5o 800 mg.kg-1) at one-half of LD5o 100 % and 80 % survival were observed at a dose of 7.5 Gy. At one-eighth of the LD50, there was still 50 % survival at a dose of 7.5 Gy.
-Derivative 45 (DRF 1.7; LD5o 80 mg.kg-1) at LD5o/1.6 100 % and 90 % survival were observed at a dose of 7.75 Gy. 70 % and 30 % survival were also obtained at doses of 9.75 and 11.75 Gy. At LD5o/6.4, there was still 80 % survival at dose of 7.75 Gy.
-Derivative 47 (DRF>1.6; LD5o 800 mg.kg-1) the administration of this product at of LD5o protects 100 % and 70 % of mice at a dose of 7.5 Gy and 90 % survival was obtained at a dose of 9.5 Gy.
At last, it is important to note the significant radioprotective activity of organogermylated sulfides 54 and 55 (DRF 1.5-1.6).
-Derivative ,54 (DRF 1.6; LD5o 1000 mg.kg-) at the MTD this product protects 100 % and 80 % of mice at doses of 7.5 and 9.5 Gy, it also protects 50 % of mice at a dose of 7.5 Gy.
-Derivative .5,5 (DRF 1.5; LD5o 800 mg.kg-1) at of LD50 100 % and 90 % protection were observed at doses of 9.5 and 11.5 Gy.
In short, several organosilylated and organogermylated compounds present a good radioprotective activity compared with the starting organic derivatives due to the presence in these molecules of organometallic groups which increase the hydrosolubility and by the presence of organic ligands which increase the liposolubility and biological activity of these molecules, thereby favouring their passage through the cellular membranes.
The results presented in this paper confirm the positive contribution of germanium and silicon in this field in agreement with previous works [1, 6-12, [20] [21] [22] and the interesting biological activity of organosilicon and organogermanium compounds in different fields .
